|
|
||||||||
Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
Submitted 22 February 2006 ; accepted in final form 25 July 2006
| ABSTRACT |
|---|
|
|
|---|
B expressions were measured using Western blotting. Moreover, plasma IL-6, estradiol, and progesterone levels were measured using ELISA or EIA kits. Results (1-way ANOVA) indicated that following T-H, 1) cardiac function was depressed in DE, E, ME, and OVX groups but maintained in the PE group; 2) the PE group had the highest plasma estrogen level; 3) plasma IL-6 levels increased significantly in DE, E, ME, and OVX groups, but the increase was attenuated in the PE group; 4) cardiomyocyte IL-6 protein level increased significantly in DE, E, ME and OVX groups after TH, but the increase was attenuated in the PE group; and 5) cardiomyocyte NF-
B expression increased significantly but was attenuated in the PE group. These data collectively suggest that the estrus cycle plays an important role in cardiac function following TH. The salutary effect seen in PE following TH is likely due to a decrease in NF-
B-dependent cardiac IL-6 pathway.
female reproductive cycle; ovariectomy; estrogen; trauma-hemorrhagic shock; interleukin-6; nuclear factor-
B
It has been shown that high estrogen levels in female rats in the proestrus cycle maintain cardiac function following trauma-hemorrhage (16). However, the estrogen levels vary in different estrus cycles, and thus, depending on the stage of estrus cycle, females may exhibit variations in their responses to trauma-hemorrhage. Studies also have shown a correlation between the sustained elevation in IL-6 levels and poor outcome following hypoxia (26, 36, 37). It also has been demonstrated that IL-6 gene expression that is induced by hypoxia is mainly through the activation of NF-
B in cardiomyocytes (24). Furthermore, the transcription factors NF-IL-6 and NF-
B are known to synergistically activate the transcription of inflammatory cytokines, chemokines, and adhesion molecules (27). More recently, we (40) found an increase in cardiac IL-6 protein levels and also increased cardiomyocyte IL-6 gene expression following trauma-hemorrhage. In this study we investigated whether different estrus cycles have an influence on cardiac function following trauma-hemorrhage and whether cardiac function under those conditions is related to cardiac IL-6 production. Thus we hypothesized that downregulation of cardiac IL-6 might be one of the mechanisms by which proestrus females have protective effects on cardiac function following trauma-hemorrhage. Since NF-
B is involved in IL-6 regulation, we also examined whether the different female reproductive cycles have any effects on NF-
B/I
B-
.
| MATERIALS AND METHODS |
|---|
|
|
|---|
B expression levels were determined by Western blot analysis.
Trauma-hemorrhagic shock model and experimental groups.
Trauma-hemorrhagic shock (34) was induced in PE, E, ME, DE, and OVX (2 wk before trauma-hemorrhage was induced) female adult (225275 g) Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) as described previously by our group, with some modifications (34, 35). In brief, all experimental rats were fasted overnight but allowed water ad libitum before the experiment. After determination of the estrus cycle, both the right and left femoral arteries and right vein were cannulated with PE-50 tubing under anesthesia with isoflurane inhalation. The tubing in the right femoral artery was connected to a blood pressure analyzer (BPA; Digi-Med, Louisville, KY) for measuring and monitoring mean arterial pressure (MAP) and heart rate (HR); the tubing in the left femoral artery was used for blood withdrawal; and the tubing in the right femoral vein was used for fluid resuscitation. The total circulating blood volume was calculated according to our previous studies (i.e., total circulating blood volume = body weight x 6%). MAP was monitored continuously before the onset of hemorrhage until the end of resuscitation. We allowed
1015 min after cannulation for the animal to awaken completely from anesthesia. The animals were bled rapidly under conscious conditions to reach MAP of 3540 mmHg within 10 min, and MAP was maintained at that level by further withdrawing blood until maximum bleed out (MBO) occurred. The amount of blood volume withdrawn to reach MBO was
60% of the total circulating blood volume. The rats were then maintained at the MAP of 40 mmHg with infusions of small volumes of Ringer lactate for 45 min, followed by fluid resuscitation with Ringer lactate (4x MBO volume) over 1 h. The total time for trauma-hemorrhage model preparation was
2.53 h. The animals were then returned to cages and allowed food and water ad libitum.
In the OVX group, ovariectomy was performed 2 wk before trauma-hemorrhage. Ovariectomy was performed by placing the animal in a prone position. A 1-cm-long incision was made on both sides of the waist under isoflurane inhalation, and ovaries on both sides were removed, blood vessels secured, and incisions closed. The experiments described were performed in adherence to the National Institutes of Health Guidelines for the Use and Care of Laboratory Animals. This project was approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham.
Estrus cycle determination. Estrus cycles were determined in early morning on the experimental day by vaginal smear. Three types of cells are found in vaginal smears: polymorphonuclear (PMN), nucleated epithelial, and cornified epithelial cells (ECs). Primarily nucleated ECs with a few cornified ECs were detected in proestrus; primarily cornified ECs with a few nucleated ECs were found in estrus, primarily PMNs with a few nucleated cornified ECs were detected in metestrus, and very few cells of all types were found in diestrus (21, 33).
Cardiac function determination. At 2 h after trauma-hemorrhage or sham operation, cardiac output (CO) was determined using the indocyanine green dilution technique (40). MAP and HR were documented using the BPA. Left ventricular performance parameters such as the maximal rate of pressure increase (+dP/dtmax) and decrease (dP/dtmax) were also measured with a heart performance analyzer (HPA; Digi-Med). Stroke volume (SV), total peripheral resistance (TPR), systemic O2 delivery, and O2 consumption were calculated according to standard equations as previously described in our studies (40).
Measurement of plasma levels of sex hormones. At the onset of trauma-hemorrhage, 2 ml of blood were collected in EDTA-coated tubes via the right carotid arterial catheter in various groups. Plasma was separated immediately by centrifugation, and samples were stored at 70°C until assayed for sex hormones. Plasma levels of estradiol and progesterone were determined by EIA kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturers instructions.
Systemic IL-6 measurement. Blood samples were collected in EDTA-coated tubes at 2 h after trauma-hemorrhage or sham operation following the measurement of cardiac function in various groups. Plasma was immediately separated by centrifugation, and samples were stored at 70°C until assayed for systemic IL-6. Systemic IL-6 levels were measured using an ELISA kit (R&D Systems, Minneapolis, MN) according to the manufacturers instructions.
Left ventricular cardiomyocytes isolation.
After measurement of cardiac function, cardiomyocytes from ventricle were isolated immediately as described previously by our group, with modifications (28). Briefly, the heart was quickly removed from the chest and perfused in a retrograde manner via the aorta at 37°C and at a consistent rate (12 mg·min1·g tissue1) for 5 min with a calcium-free Krebs buffer containing (in mM) 118 NaCl, 4.7 KCl, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, 10 HEPES, and 11 glucose, gassed with 95%O2-5%CO2. After the wash-perfusion, the calcium-free Krebs buffer was replaced by an enzymatic digestion buffer containing collagenase type II (Worthington, Lakewood, NJ), 0.1% fat-free BSA, 100 µM CaCl2, and 10 mM taurine and perfused at 37°C at a consistent rate (5 mg·min1·g tissue1) for 9 min. When the heart became swollen and hard, the left ventricle was removed and cut into small chunks (
1 x 1 mm3) and further digested with the incubation buffer containing the enzymatic digesting buffer and 2% fat-free BSA in a shaker (6070 rpm) water bath at 37°C for 10 min. The supernatant containing the dispersed cardiomyocytes was filtered through a 300-µl filter into a 50-ml sterilized tube and gently centrifuged at 500 rpm for 1 min. The upper portion of the supernatant was discarded, and
30 ml BSA-free buffer (calcium-free Krebs buffer + 50 µM CaCl2) was added and centrifuged at 480 rpm for 1 min. The upper portion of the supernatant was discarded again, and a 10-ml cell suspension was carefully layered onto high BSA (4%) medium and centrifuged (480 rpm, 1 min). The number of cardiomyocytes was then counted by suspending cardiomyocytes in 0.02% Trypan blue under a light microscope. All the buffers were filtered (0.2-µM filter) and equilibrated with 95%O2-5%CO2 for at least 20 min before use. To reduce bacterial and viral contamination, the perfusion setup was washed each day with 70% alcohol and then washed with sterilized distilled water before perfusion.
Cardiomyocyte nuclear extraction.
Isolated cardiomyocytes (
1.5 x 106) were rapidly suspended in 1 ml of hypotonic buffer including (in mM) 10 HEPES (pH 7.9), 1.5 MgCl2, 10 KCl, 0.5 DTT, 0.1 PMSF, and 10 µg/ml aprotinin. The cardiomyocytes were centrifuged at 1,500 rpm for 5 min at 4°C, and the supernatant was discarded. The packed cardiomyocytes were resuspended in hypotonic buffer and allowed to swell for 10 min on ice. The cardiomyocyte integrity was then broken using a 26.5 needle with six repeats of up-and-down pushing. The cardiomyocyte nuclei were then collected by centrifuging at 4,000 rpm for 15 min at 4°C. Finally, the packed nuclei pellet was resuspended in an equal volume of high-salt buffer including (in mM) 20 HEPES (pH 7.9), 1.5 MgCl2, 0.6 KCl, 0.2 EDTA, 0.5 DTT, 0.1 PMSF, 25% glycerol, and 10 µg/ml aprotinin for 60 min with continuous gentle mixing to extract the nuclei. The extracted cardiomyocyte nuclei were collected by centrifuging at 14,000 rpm for 15 min at 4°C. The extracted cardiomyocyte nuclei were stored at 70°C until used.
Western blot analysis of cardiomyocyte IL-6, estrogen receptor (ER)-
/ER-
, NF-
B, and I
B-
/phospho-I
B-
expression.
Approximately 1.52.0 x 106 cardiomyocytes were homogenized in 0.51 ml of lysis buffer containing (in mM) 20 HEPES (pH 7.9), 1.5 MgCl2, 20 KCl, 0.2 EDTA, 2 Na3VO4, 10 NaF, 0.2 PMSF, 20% glycerol, 1% Triton X-100, 10 µg/ml aprotinin, and 10 µg/ml leupeptin. Cardiomyocyte lysate was centrifuged at 10,000 g for 10 min at 4°C, and the protein concentration of supernatant was measured (Bio-Rad Laboratories, Hercules, CA). The lysates were analyzed on SDS-PAGE (420%), and the proteins were transferred to nitrocellulose membranes. For IL-6, ERs, and I
B-
, 40 µg of lysate per lane were loaded, whereas for NF-
B, 20 µg of cardiomyocyte nuclear extract per lane were loaded. After the transfer, the membranes were immunoblotted with anti IL-6 (Biosource International, Camarillo, CA), ER-
/ER-
, NF-
B, and I
B-
/phospho-I
B-
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), respectively, followed by the addition of horseradish peroxidase-conjugated secondary antibody. After the final wash, membranes were probed using enhanced chemiluminescence dye (ECL; Amersham Pharmacia Biotech, Piscataway, NJ) and autoradiographed. The density of the bands was determined using densitometric analysis. In addition, the membranes were reprobed using glyceraldehyde-3-phosphate dehydrogenase (Abcam, Cambridge, MA) or histone H1 (Upstate, Charlottesville, VA) as loading control.
Statistical analysis.
Data are presented as means ± SE. One-way analysis of variance and Tukeys test were employed for comparison among different groups of animals. The differences are considered significant at P
0.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
Alterations in cardiomyocyte ERs.
Cardiac ER-
expression decreased significantly in the DE and OVX groups after trauma-hemorrhage compared with shams (P < 0.05, Figs. 4, A and B); however, no difference in cardiomyocyte ER-
levels was observed in the PE group compared with shams (Fig. 4, A and B). Similarly, cardiac ER-
expression decreased significantly in the DE and OVX groups after trauma-hemorrhage (P < 0.05, Fig. 4, A and C); however, the levels in the PE group after trauma-hemorrhage were similar to those in shams (P < 0.05, Fig. 4, A and C).
|
B-
and NF-
B.
Similar levels of cardiomyocyte I
B-
expression were detected among different groups (Fig. 5, A and B); however, phospho-I
B-
expression was significantly increased in DE and OVX females after trauma-hemorrhage (P < 0.05, Fig. 5, A and C). Expression of cardiomyocyte phospho-I
B-
did not change in the PE group (Fig. 5, A and C) after trauma-hemorrhage. Cardiac NF-
B expression increased significantly following trauma-hemorrhage in the E, ME, DE, and OVX groups (P < 0.05); however, there was no significant difference in NF-
B in the PE group following trauma-hemorrhage compared with the sham group (P < 0.05, Fig. 6, A and B).
|
|
| DISCUSSION |
|---|
|
|
|---|
and ER-
expression levels were significantly decreased in DE and OVX females following trauma-hemorrhage; however, they were maintained at levels similar to those in shams in the PE group following trauma-hemorrhage. Furthermore, these levels were significantly higher compared with those in DE and OVX females following trauma-hemorrhage. It should also be noted that cardiomyocyte and plasma IL-6 levels were significantly increased in E, ME, DE, and OVX groups at 2 h after trauma-hemorrhage, whereas they were significantly attenuated in the PE group under those conditions. Although high levels of progesterone were found in E and ME females, it appears that progesterone did not have sufficient protective effects on cardiac function following trauma-hemorrhage. This conclusion may appear at variance from previous findings by our group (20), which showed that administration of progesterone (25 mg/kg body wt) in OVX rats following trauma-hemorrhage ameliorated the proinflammatory response and prevented hepatic injury under those conditions. However, it should be noted that the highest level of progesterone observed in the plasma of mice was
30 pg/mg protein, whereas 25 mg/kg progesterone was administered in the previous study (20). Thus far higher levels of progesterone are needed for progesterone to have salutary effects following trauma-hemorrhage. Our results collectively demonstrate that ovarian and gonadal sex steroids are associated with the sexual dimorphic response to trauma-hemorrhage. Previous studies by our group have shown that immunological functions are markedly depressed in males following trauma-hemorrhage but not in PE females under those conditions (1, 42). The reason for the diverse immunological effects between males and PE females appears to be due to high estradiol levels that are observed in the proestrus state (1, 16). Support for this notion comes from studies showing that OVX females responded to trauma-hemorrhage in a manner even worse than that of males. Furthermore, administration of estradiol in OVX females and even in males normalized the depressed cardiovascular and immunological responses following trauma-hemorrhage (16, 26, 40). These studies therefore suggest that the maintenance or depression of cardiac function is dependent on the estrogen levels prevailing at the time of trauma-hemorrhage. Support for this notion comes from the present study, which indicates that the PE females, which have the highest estrogen levels, maintained cardiac function following trauma-hemorrhage. Although E and ME females showed some improvement in CO, SV, and ±dP/dt compared with OVX females following trauma-hemorrhage, all of the measured parameters were not restored to normal levels. The slight improvement in the above parameters may be due to the relatively higher estrogen levels in E and ME females compared with OVX females. It therefore appears that the protective effects of estrogen on cardiac function following trauma-hemorrhage are likely due to the estrogen levels present at the time of injury.
It also appears that not only low levels of estradiol but also the levels of male sex steroids are responsible for the depression of cardiac function following trauma-hemorrhage. In this regard, Chaudry and colleagues (1, 2) have previously demonstrated that administration of testosterone-releasing pellets in female mice caused a significant decrease in plasma levels of 17
-estradiol and a marked depression in immune functions similar to that observed in males. A previous study by our group (19) has shown that differences in the regulation of plasma and tissue volumes exist between males and proestrus females during and after trauma-hemorrhage. The increased circulating blood volume could therefore contribute to the improvement in cardiac and immune functions in PE females in various adverse circulatory conditions. Previous studies by our group also have shown that the anterior pituitary hormone prolactin is higher in PE females and that prolactin has salutary effects on cell and organ functions following trauma-hemorrhage (1). Nonetheless, it remains to be determined whether the high levels of estradiol alone or the combination of the two (increased estradiol and prolactin) are responsible for the maintenance of cardiac function in PE females following trauma-hemorrhage. The exact mechanism by which ovarian and anterior pituitary hormones improve organ functions after adverse circulations also remains to be determined.
Studies have reported that IL-6 plays a role in sex-specific alterations in organ functions following trauma-hemorrhage, burn, and sepsis (4, 8, 10, 32, 40). This cytokine is a multifunctional cytokine that affects numerous cell types. IL-6 plays a central role in diverse host defense mechanisms such as the immune response, hematopoiesis, and acute-phase reactions (1, 29). Our previous studies have demonstrated that plasma IL-6 levels were significantly elevated at 24 h after trauma-hemorrhage; however, administration of estradiol during resuscitation downregulated trauma-hemorrhage-induced increase in plasma IL-6 (40). More recently, we have found that the beneficial effects of estradiol on cardiac function following trauma-hemorrhage appear to be due in part to the decreased IL-6 synthesis in cardiomyocytes (40). Although our previous studies suggest that Kupffer cells are the primary source of circulatory IL-6 levels, we found that cardiomyocytes also can synthesize IL-6 and that the local production of IL-6 plays a key role in regulating cardiac function following adverse circulatory conditions (40). In the present study, plasma IL-6 levels were increased at 2 h after trauma-hemorrhage and resuscitation, and the elevated plasma and cardiac IL-6 levels in E, ME, DE, and OVX females were associated with adverse effects on cardiac function. However, in PE females the level of IL-6 following trauma-hemorrhage was not significantly different from that observed in sham animals. Since the levels of estrogen are highest in the PE state, it is likely that the elevated level of estrogen in PE females downregulates cardiomyocyte IL-6 production and thus protects cardiac functions following trauma-hemorrhage. To establish the relationship between cardiac IL-6 and cardiac function following trauma-hemorrhage, we administered goat anti-rat-IL-6 monoclonal antibody at the middle of resuscitation after trauma-hemorrhage to neutralize IL-6 and measured the effect of this treatment on cardiac function following trauma-hemorrhage. Our results suggested that treatment of animals with anti-IL-6 antibodies downregulated cardiac IL-6 and improved cardiac function (39).
The protective effects of estrogen in cardiovascular diseases are currently under intensive investigation because of the potential therapeutic hormone effects (7, 25). However, the molecular mechanism by which estrogen downregulates cardiac IL-6 production is still not fully understood. Studies have demonstrated that estradiol attenuates cytokine production by inhibiting the transcription factor (nuclear factor) NF-
B (18). NF-
B is a pleiotropic transcription factor implicated in the regulation of diverse biological phenomena, including the cellular responses to stress, hypoxia, ischemia (18), and hemorrhagic shock (13). Studies have shown that NF-
B is activated in various heart diseases such as myocarditis, congestive heart failure, dilated cardiomyopathy, and heart transplant rejection (18). In the heart, NF-
B is found to be activated following burn, ischemia-reperfusion, and hypoxia (23, 24, 28). Moreover, studies have demonstrated that induction of IL-6 by hypoxia, a condition associated with trauma-hemorrhage, is mediated by NF-
B and NF-IL-6 in cardiomyocytes (28) and that hypoxia induces IL-6 gene expression through NK-
B activation (3). NF-
B and I
B-
interact in an autoregulatory mechanism (24). Transcription factors NF-IL-6 and NF-
B are known to synergistically activate the transcription of inflammatory cytokines (23). Studies also have shown that hypoxia-induced transcriptional activation of IL-6, i.e., IL-6 gene expression, is induced mainly through the activation of NF-
B in cardiomyocytes (29). Studies also have shown that estrogen represses IL-6 gene expression through inhibition of the DNA-binding activities of the transcription factors NF-IL-6 and NF-
B by the ERs (31). The present findings suggest a relationship between the increased cardiac IL-6 and the cardiac NF-
B/I
B-
system following trauma-hemorrhage. Thus the normalized cardiac function following trauma-hemorrhage in PE females also may be due to inhibition of the NF-
B/I
B system. Females in the PE cycle had a significantly attenuated increase in cardiac NF-
B and improvement in cardiac function under those conditions. It also has been demonstrated that JAK2/STAT3, not ERK1/2, mediates IL-6-induced activation of inducible NO synthase and a decrease in contractility of adult ventricular myocytes (41). Studies also have shown that estrogen inhibits growth hormone (GH) signaling by suppressing GH-induced JAK2 phosphorylation, and the suppressors of cytokine signaling (SOCS) play a central mechanistic role. Moreover, STAT3 is a molecular participant in ER inhibition of the IL-6 signaling pathway (21). In addition, studies have indicated sexual dimorphism in the permeability response of coronary microvessels to adenosine (15). Nonetheless, the precise mechanisms of estrogens effect in the attenuation of IL-6 following trauma-hemorrhage remain to be clarified.
In summary, the present results suggest that cardiac function was significantly depressed at 2 h after trauma-hemorrhage and resuscitation in E, ME, DE, and OVX female rats; however, it was maintained in PE females under those conditions. Furthermore, cardiomyocyte IL-6 expression and plasma IL-6 levels significantly increased after trauma-hemorrhage in E, ME, DE, and OVX female rats. Nonetheless, the increases in cardiomyocyte IL-6 expression as well as systemic IL-6 were not apparent in PE females. Moreover, the cardiomyocyte NF-
B/I
B-
system was activated in E, ME, DE, and OVX females following trauma-hemorrhage; however, it was inhibited in PE females. These data collectively suggest that the estrus cycle plays an important role in cardiac function following trauma-hemorrhage. The salutary effect seen in PE females following trauma-hemorrhage is likely due to a decrease in NF-
B-dependent cardiac IL-6 pathway.
| GRANT |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
B proteins: multifunctional regulators of Rel/NF-
B transcription factors. Genes Dev 7: 20642070, 1993.
B activation in murine macrophages. Am J Reprod Immunol 38: 4654, 1997.
B as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol 3: 229254, 2003.[CrossRef][Medline]
B and NF-IL6 in cardiac myocytes. Cardiovasc Res 42: 104112, 1999.
B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90: 1019310197, 1993.
B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265: 2112821133, 1990.
B activation. Transplantation 63: 466470, 1997.[CrossRef][ISI][Medline]
-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-
B by the estrogen receptor. FEBS Lett 409: 7985, 1997.[CrossRef][ISI][Medline]This article has been cited by other articles:
![]() |
J. L. Sperry and J. P. Minei Gender dimorphism following injury: making the connection from bench to bedside J. Leukoc. Biol., March 1, 2008; 83(3): 499 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Choudhry and I. H. Chaudry 17{beta}-Estradiol: a novel hormone for improving immune and cardiovascular responses following trauma-hemorrhage J. Leukoc. Biol., March 1, 2008; 83(3): 518 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frink, B. M. Thobe, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry 17beta-Estradiol inhibits keratinocyte-derived chemokine production following trauma-hemorrhage Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L585 - L591. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |